chr15-51208341-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000103.4(CYP19A1):​c.*2467G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.237 in 152,012 control chromosomes in the GnomAD database, including 4,513 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4513 hom., cov: 31)
Failed GnomAD Quality Control

Consequence

CYP19A1
NM_000103.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0560

Publications

9 publications found
Variant links:
Genes affected
CYP19A1 (HGNC:2594): (cytochrome P450 family 19 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and catalyzes the last steps of estrogen biosynthesis. Mutations in this gene can result in either increased or decreased aromatase activity; the associated phenotypes suggest that estrogen functions both as a sex steroid hormone and in growth or differentiation. Alternative promoter use and alternative splicing results in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016]
MIR4713HG (HGNC:53124): (MIR4713 host gene)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 15-51208341-C-T is Benign according to our data. Variant chr15-51208341-C-T is described in ClinVar as Benign. ClinVar VariationId is 316442.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.314 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000103.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP19A1
NM_000103.4
MANE Select
c.*2467G>A
3_prime_UTR
Exon 10 of 10NP_000094.2
CYP19A1
NM_001347248.1
c.*2467G>A
3_prime_UTR
Exon 10 of 10NP_001334177.1P11511-1
CYP19A1
NM_001347249.2
c.*2467G>A
3_prime_UTR
Exon 10 of 10NP_001334178.1P11511-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP19A1
ENST00000396402.6
TSL:1 MANE Select
c.*2467G>A
3_prime_UTR
Exon 10 of 10ENSP00000379683.1P11511-1
MIR4713HG
ENST00000559909.1
TSL:4
n.195-69642C>T
intron
N/A
MIR4713HG
ENST00000805692.1
n.279-69642C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.237
AC:
36051
AN:
151894
Hom.:
4508
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.318
Gnomad AMI
AF:
0.121
Gnomad AMR
AF:
0.183
Gnomad ASJ
AF:
0.216
Gnomad EAS
AF:
0.185
Gnomad SAS
AF:
0.285
Gnomad FIN
AF:
0.196
Gnomad MID
AF:
0.348
Gnomad NFE
AF:
0.210
Gnomad OTH
AF:
0.212
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.237
AC:
36089
AN:
152012
Hom.:
4513
Cov.:
31
AF XY:
0.238
AC XY:
17677
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.318
AC:
13189
AN:
41440
American (AMR)
AF:
0.183
AC:
2789
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.216
AC:
751
AN:
3470
East Asian (EAS)
AF:
0.185
AC:
956
AN:
5176
South Asian (SAS)
AF:
0.285
AC:
1367
AN:
4796
European-Finnish (FIN)
AF:
0.196
AC:
2077
AN:
10580
Middle Eastern (MID)
AF:
0.353
AC:
103
AN:
292
European-Non Finnish (NFE)
AF:
0.210
AC:
14295
AN:
67972
Other (OTH)
AF:
0.215
AC:
452
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1381
2761
4142
5522
6903
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
384
768
1152
1536
1920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.220
Hom.:
504
Bravo
AF:
0.234
Asia WGS
AF:
0.253
AC:
880
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Aromatase deficiency (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.6
DANN
Benign
0.19
PhyloP100
-0.056
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs934634; hg19: chr15-51500538; API